Surgical Management of Giant Prolactinomas: A Descriptive Study
Introduction. Giant prolactinoma (GP) is a rare pituitary lactotropic cell tumor larger than 4 cm in its widest dimension, and is less likely than a smaller prolactinoma to achieve prolactin normalization on dopamine agonist (DA) monotherapy. There is a paucity of data on the circumstances and outco...
Saved in:
| Main Authors: | Michelle D. Lundholm, Divya Yogi-Morren, Kevin M. Pantalone, Pablo F. Recinos, Varun R. Kshettry, Pratibha P. R. Rao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2023/1990259 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IPSS does not impact management in Cushing's Disease when a pituitary tumor is visible on MRI
by: Michelle D. Lundholm, et al.
Published: (2025-12-01) -
Prolactinomas: Aspectos neurocirúrgicos Prolactinomas: neurosurgical aspects
by: Oswaldo Inácio Tella Jr, et al.
Published: (2002-03-01) -
Management of prolactinoma during pregnancy and postpartum
by: Om J Lakhani, et al.
Published: (2015-01-01) -
Correction: Giant prolactinoma with progressive cranial settling and central herniation: a case report
by: Taha Shahbazi, et al.
Published: (2025-01-01) -
Avaliação plasmática de igf-1 no prolactinoma IGF-1 plasma levels evaluation in prolactinoma
by: Daniela Zylberberg, et al.
Published: (2006-09-01)